Napoli M, Sitaru S, Budke A, Kammerl A, Querner G, Immler R, Rohwedder I, Seifert S, Ferraro B, Weckbach L, Catz S, Aramini A, Amendola PG, Allegretti M, Bertini R, Pruenster M, Sperandio M. The dual non-competitive CXCR1/2 inhibitor ladarixin impairs neutrophil extravasation without altering intravascular adhesion. haematol [Internet]. 2020Sep.10 [cited 2026Feb.6];. Available from: https://haematologica.org/article/view/12235